Neuronetics (STIM) 10% holder buys stock, exits call options
Rhea-AI Filing Summary
Neuronetics, Inc. insider Jorey Chernett, a ten percent owner, reported mixed transactions. On 2026-08-14 he purchased 14,000 shares of common stock at a weighted average price of $3.16 per share, in multiple trades between $3.13 and $3.17, bringing his direct holdings to 10,602,988 shares. On 2026-08-13 he sold 100 call option contracts on Neuronetics common stock (underlying 10,000 shares) at $3.21 per option-share with a $5.00 strike price expiring on 2027-02-19, leaving no remaining position in these options. The option sale is described as a matchable transaction under Section 16(b), and Chernett states he intends to disgorge the calculated short-swing profit to Neuronetics. The transactions were not reported as made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 14,000 shares
Net Buy
2 txns
Insider
Chernett Jorey
Role
10% Owner
Bought
14,000 shs ($44K)
Sold
100 shs ($321.00)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 14,000 | $3.16 | $44K |
| Sale | Call Option (STIM 19FEB27 $5C) F2 | 100 | $3.21 | $321.00 |
Holdings After Transaction:
Call Option (STIM 19FEB27 $5C) — 0 shares (Direct);
Common Stock — 10,602,988 shares (Direct)
Footnotes (2)
- F1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.13 tgo $3.17 rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
- F2. The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Key Figures
Common shares purchased: 14,000 shares
Weighted average purchase price: $3.16 per share
Shares owned after purchase: 10,602,988 shares
+5 more
8 metrics
Common shares purchased
14,000 shares
Common stock bought on 2026-08-14 in open market transactions
Weighted average purchase price
$3.16 per share
Price for 14,000-share common stock purchase, trades from $3.13 to $3.17
Shares owned after purchase
10,602,988 shares
Direct Neuronetics common stock holdings following the 14,000-share purchase
Call option contracts sold
100 contracts
Derivative sale on 2026-08-13, underlying 10,000 Neuronetics common shares
Underlying shares for options
10,000 shares
Common stock underlying the 100 call options sold
Option sale price
$3.21 per option-share
Per-share-equivalent price received for the 100 call option contracts
Option strike price
$5.00 per share
Exercise price of the call options sold, expiring 2027-02-19
Option expiration date
2027-02-19
Expiration for the STIM 19FEB27 $5C call options sold
Key Terms
weighted average price, matchable transaction, Section 16(b), short-swing profit
4 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price, rounded to"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
matchable transaction regulatory
"The sale of these call options is a matchable transaction subject to"
Section 16(b) regulatory
"matchable transaction subject to Section 16(b) of the Securities Exchange"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
short-swing profit financial
"The reporting person has calculated a short-swing profit in connection"
Short-swing profit is any gain an insider makes from buying and selling (or selling and buying) the same company's stock or options within a six-month window; regulators treat those quick trades as presumptively improper and typically require the profits to be returned. Think of it like flipping a concert ticket for a quick markup — the law prevents insiders with privileged access from keeping those fast gains, which protects ordinary investors and promotes fair markets.
FAQ
What insider transactions did Jorey Chernett report in Neuronetics (STIM) on this Form 4?
Jorey Chernett reported mixed transactions: a common stock purchase and an option sale. He bought 14,000 STIM shares and sold 100 call option contracts tied to 10,000 underlying shares, both in mid-August 2026.
What call options on Neuronetics (STIM) did Jorey Chernett sell and on what terms?
Chernett sold 100 STIM call option contracts covering 10,000 shares at $3.21 per option-share. The options have a $5.00 strike price and an expiration date of 2027-02-19, and this sale reduced his position in these options to zero.
How does Section 16(b) affect the option sale reported by Jorey Chernett in STIM?
The filing states the call option sale is a matchable transaction under Section 16(b). Chernett has calculated a short-swing profit from matchable trades and reports that he intends to disgorge this profit to Neuronetics.
Were Jorey Chernett’s Neuronetics (STIM) transactions made under a Rule 10b5-1 trading plan?
No. The Rule 10b5-1 checkbox is not marked as affirming a trading plan. There is also no footnote stating that either the common stock purchase or the call option sale was executed pursuant to any pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
